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Background: An Omega-3 Index (O3I; EPA+DHA as a % of erythrocyte total fatty acids) in the desirable 
range (8%-12%) has been associated with improved heart and brain health. 
Objective: To determine the combination of fish intake and supplement use that is associated with an O3I 
of >8%. 
Design: Two cross-sectional studies comparing the O3I to EPA+DHA/fish intake. 
Participants/setting: The first study included 28 individuals and assessed their fish and EPA+DHA intake 
using both a validated triple-pass 24-hr recall dietary survey and a single fish-intake question. The second 
study used de-identified data from 3,458 adults (84% from US) who self-tested their O3I and answered 
questions about their fish intake and supplement use. 
Statistical analyses performed: Study 1, chi-squared, one-way ANOVA, and Pearson correlations were 
computed. In Study 2, multi-variable regression models were used to predict O3I levels from reported fish/
supplement intakes. 
Results: The mean ± SD O3I was 4.87 ± 1.32%, and 5.99 ± 2.29% in the first and second studies, 
respectively. Both studies showed that for every increase in fish intake category the O3I increased by 
0.50–0.65% (p < 0.0001). In the second study, about half of the population was taking omega-3 
supplements, 32% reported no fish intake and 17% reported eating fish >2 times per week. Taking an 
EPA+DHA supplement increased the O3I by 2.2% (p < 0.0001). The odds of having an O3I of ≥8% were 
44% in the highest intake group (≥3 servings/week and supplementation) and 2% in the lowest intake 
group (no fish intake or supplementation); and in those consuming 2 fish meals per week but not taking 
supplements (as per recommendations), 10%. 
Conclusion: Current AHA recommendations are unlikely to produce a desirable O3I. Consuming at least 3 
fish servings per week plus taking an EPA+DHA supplement markedly increases the likelihood of 
achieving this target level. 
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ABSTRACT 20 
Background. An Omega-3 Index (O3I; EPA+DHA as a % of erythrocyte total fatty acids) in the 21 
desirable range (8%-12%) has been associated with improved heart and brain health.  22 
Objective. To determine the combination of fish intake and supplement use that is associated 23 
with an O3I of >8%.  24 
Design. Two cross-sectional studies comparing the O3I to EPA+DHA/fish intake.  25 
Participants/setting. The first study included 28 individuals and assessed their fish and 26 
EPA+DHA intake using both a validated triple-pass 24-hr recall dietary survey and a single fish-27 
intake question. The second study used de-identified data from 3,458 adults (84% from US) who 28 
self-tested their O3I and answered questions about their fish intake and supplement use.  29 
Statistical analyses performed. Study 1, chi-squared, one-way ANOVA, and Pearson correlations 30 
were computed. In Study 2, multi-variable regression models were used to predict O3I levels 31 
from reported fish/supplement intakes.  32 
Results. The mean ± SD O3I was 4.87 ± 1.32%, and 5.99 ± 2.29% in the first and second studies, 33 
respectively. Both studies showed that for every increase in fish intake category the O3I 34 
increased by 0.50-0.65% (P<0.0001). In the second study, about half of the population was 35 
taking omega-3 supplements, 32% reported no fish intake and 17% reported eating fish >2 times 36 
per week. Taking an EPA+DHA supplement increased the O3I by 2.2% (P<0.0001). The odds of 37 
having an O3I of ≥8% were 44% in the highest intake group (≥3 servings/week and 38 
supplementation) and 2% in the lowest intake group (no fish intake or supplementation); and in 39 
those consuming 2 fish meals per week but not taking supplements (as per recommendations), 40 
10%.  41 
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Conclusions. Current AHA recommendations are unlikely to produce a desirable O3I. 42 
Consuming at least 3 fish servings per week plus taking an EPA+DHA supplement markedly 43 
increases the likelihood of achieving this target level. 44 
Keywords: omega-3 fatty acids, omega-3 index, eicosapentaenoic acid, docosahexaenoic acid, 45 
food frequency questionnaire, dietary records, fish, dietary supplements 46 
Abbreviations: American Heart Association, AHA; eicosapentaenoic acid, EPA 47 
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1. INTRODUCTION 53 
In 2018, the American Heart Association (AHA) updated its 2002 recommendations 54 
regarding fish and seafood consumption from “…a variety of (preferably oily) fish at least twice 55 
a week” [1] to “…1 to 2 seafood meals per week” [2]. This apparent downgrade in the 56 
recommendation (i.e., removal of “preferably oily” and “at least”) was made despite evidence 57 
that consuming fish more frequently (such as daily or multiple times per day) may impart even 58 
greater cardioprotection [3-5]. An online commentary by Kuller that accompanied the 59 
publication of the new AHA guidelines questioned whether the new fish intake recommendations 60 
would produce cardioprotective blood omega-3 levels [6]. He argued that intake 61 
recommendations should be based on those that achieve a target blood level.  62 
Asking individuals about their fish intake is often a proxy measure for intake of omega-3 63 
fatty acids (FAs) eicosapentaenoic (EPA) and docosahexaenoic acids (DHA), because, in nature, 64 
EPA and DHA are found almost exclusively in oily fish, such as salmon, herring and mackerel. 65 
Blood levels of EPA and DHA have been shown to be related to reported fish intake [7] and 66 
supplementation [8], and to cardiovascular health [9], a single biomarker representing both 67 
dietary intake and risk for disease.  68 
The Omega-3 Index (O3I) is a measure of the proportion of EPA and DHA in 69 
erythrocytes (EPA+DHA/total FAs) and was originally proposed as a risk factor for cardiac 70 
death in 2004 by Harris and Von Schacky [10]. Recently, a pooling study of 10 cohort studies 71 
confirmed that an O3I of 8% was related to a risk reduction of 35% for cardiovascular death, as 72 
compared to 4% (typical O3I in low-fish intake individuals) [9]. While the O3I is a significant 73 
predictor of fatal cardiovascular events, research has shown that higher blood omega-3 levels are 74 
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beneficially related to other aging-related health conditions also, such as congitive function [11] 75 
and brain volume [12] and increased longevity [13, 14].  76 
There is some controversy regarding the effects of fish intake on the O3I. For example, 77 
Block et al reported that individuals reporting an intake of at least 2 fish meals per week had an 78 
O3I of 5.1% [7], and Harris et al. found that after 4 months of consuming 2 oily fish meals per 79 
week, the mean O3I was 6.1% [15]. On the other hand, Sands et al. reported a mean O3I of 8% 80 
in non-supplementing subjects reporting this weekly intake [16]. So, whether a diet including 81 
only 2 servings of fish per week would result in a cardioprotective O3I (8%) or not is unclear.  82 
To address this question, we conducted two studies. The first was a small but intensive study 83 
using standard dietary intake tools to quantify both fish and EPA+DHA intake and then to 84 
correlate these with the O3I. The second was conducted in a “real-world” setting to determine 85 
the associations between self-reported intake of fish and/or omega-3 (i.e., EPA and DHA) 86 
supplements and the O3I.   87 
  88 
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2. SUBJECTS AND METHODS 89 
2.1 Study 1 90 
 The study utilized a cross-sectional design with one clinic visit and three, 24-hour dietary 91 
recalls collected within two weeks of the visit.  A sample of generally healthy adults was 92 
recruited by email and fliers in two sites, State College, PA and Sioux Falls, SD, US, and 93 
screened via telephone or in person during the summer of 2009.  Eligibility criteria included 94 
generally healthy men and women, aged 19-65 years, BMI 19-40 kg/m2, not taking any fish oil 95 
or other EPA or DHA-containing supplements within the last 2 months, not taking flaxseed oil 96 
supplements within the last week, and having a stable diet pattern, especially with respect to 97 
seafood, for the previous 6 months. Those who were ineligible were pregnant or nursing, ill, 98 
taking prescription medications, smokers, or did not fit into an available fish intake group (see 99 
below). Thirty participants were recruited; 28 were eligible and had reasonable responses on the 100 
questionnaires. The study visit consisted of a finger prick to collect a dried blood spot, a short 101 
questionnaire, and measuring height and weight. The Institutional Review Boards at both sites 102 
(Penn State and Sanford Research, Sioux Falls, SD) approved all study procedures. 103 
2.1.1 Dietary Assessment 104 
 The dietary assessment consisted of triplicate 24-hour dietary recalls, and a single 105 
screening question derived from the Cardiovascular Health Study [17]. Three dietary recalls were 106 
collected via telephone by trained interviewers at The Pennsylvania State University Diet 107 
Assessment Center within 2 weeks of the clinic visit. Dietary intake data were analyzed by using 108 
the Nutrition Data System for Research software, version 2009, developed by the Nutritional 109 
Coordinating Center at the University of Minnesota, Minneapolis, Minnesota.  Diet recalls were 110 
conducted on unannounced, random, non-consecutive days with at least one weekend day of data 111 
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by using a multi-pass methodology [18, 19].  At the clinic visit, a single screening question was 112 
used to estimate the person’s perceived, average intake of “fatty” fish [7]. The screening question 113 
was, “How often do you eat—as a main course—tuna or other non-fried fish?” Possible 114 
responses were a) 1 or fewer times per month, b) 2-3 times per month, c) 1 time per week, d) 2 115 
times per week, or e) more than 2 times per week. A serving was defined as 3 ounces to the 116 
participants.  Recruitment continued until six participants in each of the five fish intake 117 
categories above had been enrolled.  118 
2.2 Study 2 119 
Data were derived from 3,458 individuals who 1) sent in a dried blood spot to 120 
OmegaQuant, LLC (Sioux Falls, SD, US) for testing between March 30, 2017 – January 15, 121 
2018, 2) answered questions regarding their fish and omega-3 supplement intake (see below), 122 
and 3) were at least 18 years of age. Individuals purchased O3I tests directly online, or they were 123 
tested at conferences or expositions, by their health care provider, or in workplace screenings. 124 
Identifying information (names, physical addresses [except state and country], email addresses, 125 
phone numbers) were removed from the dataset. The dataset contained samples from 28 126 
countries. Approval to use de-identified, existing data was obtained from the University of South 127 
Dakota Institutional Review Board. 128 
2.2.1 Dietary and Demographic Information 129 
Individuals completed a short form included in their blood sample collection kit. This 130 
form included personal contact information for returning results as well as some demographic 131 
(age, sex, country) and dietary intake information. The fish-related dietary question was the same 132 
as asked in Study 1, however the possible responses were slightly different: “None per week,” 133 
“Every other week,” “Every week,” “2 times per week,” and “3 or more times per week.” The 134 
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supplement-related questions were as follows: “Do you take an omega-3 supplement?” with the 135 
responses: “Yes” or “No.” If yes, they were asked which kind of supplement: “Fish oil,” “Krill 136 
oil,” “Algal oil,” and “Flaxseed oil.” The supplements with EPA+DHA (krill, fish, and algal oils; 137 
n=1,681) were included in the “EPA+DHA supplement” category, but individuals who reported 138 
taking flaxseed oil (n=45) or did not report the kind of supplement (n=75) were excluded from 139 
this analysis.  140 
2.3 Omega-3 Index Analysis  141 
In both studies, an O3I kit was used to collect a dried blood spot as previously described 142 
[20]. After receipt in the laboratory, capillary column gas chromatography was used with an 143 
internal-standard-based, three-point calibration curve to quantify levels of 24 FAs. Blood spots 144 
were transferred to a reaction vial. FA methyl esters were generated using boron trifluoride in 145 
methanol as a methylation reagent. Samples were heated for 45 min at 100C, extracted into 146 
hexane (after the addition of water) and analyzed using a GC2010 Gas Chromatograph 147 
(Shimadzu Corporation, Columbia, MD) equipped with a SP2560, 100-m column (Supelco, 148 
Bellefonte, PA). FA were identified by comparison with a standard mixture of FA (GLC, 149 
Nucheck Prep, Elysian, MN). The O3I (an erythrocyte-specific metric) was calculated from the 150 
dried blood spot EPA+DHA value using an equation derived by comparing values in 98 random 151 
samples and is expressed as a percent of total FAs. The correlation coefficient between O3I and 152 
the dried blood spot EPA+DHA was 0.96 (P<0.0001). The laboratory coefficient of variation for 153 
the O3I is <5%. All individual FA, including EPA and DHA, are whole blood levels.  154 
2.4 Statistical Analyses 155 
In study 1, demographic characteristics were compared across fish intake groups using 156 
chi-squared and one-way ANOVA methods, with p-values also estimated using a resampling 157 
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approach to ensure robustness due to small sample sizes within each category. Pearson 158 
correlations were computed between the O3I and both the frequency of intake (1 question) and 159 
the calculated EPA+DHA intake from the dietary recalls, with multiple regression models used 160 
to estimate correlations after adjusting for demographic factors (BMI, age, sex, race). In study 2, 161 
multiple regression models were used to estimate the adjusted effects of intake frequency and 162 
supplementation on blood FA levels, after adjusting for demographic covariates. Seventy-five 163 
percent prediction intervals are calculated in order to provide estimates of the range of O3I 164 
values based on reported fish consumption, supplement and age, based on a multiple regression 165 
model. A significance level of 0.05 and two-sided tests were used for all analyses which were 166 
run using R version 3.5 (www.r-project.org).  167 
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3. RESULTS 168 
3.1 Study 1 (n=28) 169 
Demographic characteristics were not significantly different among the five fish intake 170 
groups (Table 1). Overall, the mean age was 32 years and BMI, 24.3 kg/m2.  All participants 171 
were from the US, 82% were Caucasian, and 75% were female (Table 1). Based on the 24-hour 172 
dietary recall data, the most commonly eaten fish was tuna (32% of fish eaten) followed by 173 
salmon (16%), both of which are species known for their high EPA+DHA content.  Eight other 174 
varieties of fish and shellfish (cod, imitation crab, shrimp, haddock, catfish, swordfish, mussel, 175 
sardines) were significant contributors of EPA+DHA (based on providing at least 0.05g 176 
EPA+DHA in the meal- not energy adjusted).  Estimated overall EPA+DHA intakes were 300 177 
mg/d (assuming 2000 kcal intake, Table 1), ranging from about 34 to 620 mg/day across fish 178 
intake categories. 179 
The association between the O3I (and whole blood EPA and DHA separately) and both 180 
the five fish intake groups and the calorie-adjusted intake of EPA and DHA were significant. For 181 
the former comparison, the Pearson correlation coefficients were 0.48 for EPA (p=0.009), 0.59 182 
for DHA (p<0.001) and 0.61 for the O3I (p<0.001). There was an estimated 0.6 percentage point 183 
increase in the O3I for each additional fish consumption category (Table 2). In a multivariable 184 
model containing all four subject demographic factors and reported fish consumption frequency, 185 
only the latter was a significant predictor of the O3I. The associations between the O3I and 186 
calculated EPA and DHA intakes were weaker than those comparing the former with fish intake 187 
frequency. Correlations between blood FAs and calculated intakes were 0.26 for EPA (p=0.17), 188 
0.44 for DHA (p=0.02), and 0.42 for the O3I (p=0.03). Correlations between fish frequency 189 
group and calculated EPA+DHA intakes were 0.61 (EPA), 0.59 (DHA) and 0.61 (EPA+DHA).  190 
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3.2 Study 2 (n=3,458) 191 
The mean age of this cohort was 51 years, over half were women (60%), and they were 192 
primarily from the US (84%) (Table 3). Approximately half of the sample reported taking an 193 
EPA+DHA supplement at the time of the study (includes fish, krill and algal oil supplements). 194 
Slightly less than one third of the sample reported never eating fish, with another similarly sized 195 
group reporting each fish approximately every other week, and the remaining individuals 196 
reporting fish consumption at least weekly (38%). About 83% of individuals had an O3I below 197 
the desirable range of 8%-12%, 16% had values within that range, and 2% had values above. 198 
Individuals taking EPA+DHA supplements and/or eating fish more frequently had higher 199 
O3I values (Figure 1, Table 4). Furthermore, older individuals and individuals from outside of 200 
the US tended to have higher O3I values (Table 4). All variables remained statistically 201 
significant in a multi-variable model predicting O3I values, with an estimated increase of 2.2% 202 
when taking an EPA+DHA supplement, and an estimated 0.6% increase for each additional fish 203 
meal per week. The multi-variable model explained 32.7% of the variance in the O3I.  204 
Using a multivariable model including only age, reported frequency of fish intake, and 205 
omega-3 supplement use, a hypothetical 50-yr old person who did not take supplements and 206 
reported no fish intake would be predicted to have an O3I of about 4.5% (75% prediction 207 
interval [PI]: 2.3% to 6.7%.) At the other extreme, the same individual reporting both 208 
supplement use and three or more fish meals per week would have an O3I of 8.6% (75% PI, 209 
6.4% to 10.8%) (Table 5).  210 
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4. DISCUSSION 211 
 The overall purpose of these studies was to answer the question, “How much EPA+DHA 212 
from fish and/or supplements is needed to achieve a desirable O3I?” Using the answers to two 213 
simple dietary questions – “How often to you eat tuna or other non-fried fish?” and, “Do you 214 
take an omega-3 supplement?” – allowed us (along with age) to begin to answer that question.  215 
Two studies were reported here. The aim of the first study was to determine whether the 216 
answer to a simple fish intake question was as good as a calculated EPA+DHA intake from an 217 
intensive, triple 24-hr recall intake survey, with regards to their correlations with the O3I. We 218 
found stronger correlations with the O3I for the one question than for the more rigorous (but 219 
apparently less useful) recall method. The reason for this is likely that for nutrients (like EPA 220 
and DHA) that are provided in high amounts by a very small number of foods, a 3-day diet 221 
record is very unlikely to capture the “true” average intake. If the fish meal day happens to be 222 
included in the 3 days, the overall average intake will be over-estimated; if the fish meal is not 223 
eaten in that 3 day window, the average intake will be under-estimated. This increases variability 224 
and thus lowers correlations with biomarkers that actually do represent an average intake. The 225 
aim of the second study was to determine, in a large cohort of people who self-reported fish and 226 
supplement intake, what combination of these two sources of EPA and DHA was required 227 
achieve an O3I of >8%. We found that those with the best chance (44%) of achieving an 228 
desirable O3I were reporting the consumption of at least 3 fish meals a week and were taking an 229 
EPA+DHA supplement.  230 
It is of interest to know how much EPA+DHA would be provided by >2 fish meals/wk + 231 
supplementation. We estimated this using the following assumptions: 1) a serving of oily fish 232 
provides about 1,250 mg EPA+DHA (average amount provided by 4 oz of wild coho salmon, 233 
13 
 
Bluefin tuna, sardines and Albacore tuns, from USDA Nutrient Database[21]), and 2) a standard 234 
fish oil capsule contains about 300 mg EPA+DHA. Based on these values, amount of 235 
EPA+DHA from fish for 3 servings per week would be 3,750 mg/wk (or 535 mg EPA+DHA per 236 
day). Add 300 mg EPA+DHA per day from one supplement, and the overall intake equals 237 
around 835 mg EPA+DHA per day. This is approximately how much EPA+DHA one would 238 
need to consume in the long-term to achieve an average O3I of 8%, but it is >3 times the 239 
EPA+DHA recommended by the Dietary Guidelines for Amercians (250 mg/day) [22], and 1.7 240 
times that recommended by the Academy of Nutrition and Dietitics (500 mg/day) [23]. It is also 241 
about 8 times the typical EPA+DHA intake in the US (~100 mg/day) [24]. Only about 10% of 242 
Americans eat as much as 2 fish meals per week [DGAC 2015]. Not surprisingly, an estimated 243 
95% of Americans do not have optimal O3I levels [25]. In 2007 we reported that 2 fish meals per 244 
week (salmon and albacore tuna) provided an average of 485 mg EPA+DHA per day, and after 245 
months of this regimen, the mean O3I increased from 4% to 6.2% [15]. This observation further 246 
underscores the inability of the AHA recommendations to produce an optimal O3I. 247 
 Therefore, there is a discrepancy between the amount of EPA+DHA provided by current 248 
fish intake recommendations (250-500 mg/d) vs. the amount needed by most Americans to reach 249 
an O3I of 8% (>800 mg/d, according to our calculations). As Kuller wrote in a commentary on 250 
the 2018 AHA fish intake guidelines, “The key public health question is whether the 251 
recommended intake of seafood in the US should be [set so as] to reach the same levels of n-3 252 
PUFAs in blood as in Japan, about 9% of total FAs in blood versus 4% in the US [26].” Based on 253 
this rationale (and our data), at least 2-3 servings per week of oily fish, rather than “1-2 servings 254 
of seafood” [2], should be the recommendation. But even this will not produce an O3I of >8% - 255 
to achieve that, either adding an EPA+DHA supplement or increasing to 4-5 servings of oily fish 256 
per week would be necessary.  257 
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What was the basis for the AHA’s recommendation of “1-2 seafood meals per week?” 258 
Rimm et al.[2] stated that “…there is little additional benefit in risk reduction with a higher 259 
intake [than 1-2 servings per week].” This, in our view, does not reflect the current state of the 260 
data. Considerable evidence supports the view that higher fish intakes and higher blood levels of 261 
omega-3s are associated with significant additional reduction in cardiovascular risk [3, 5, 27, 262 
28], in a dose-dependent manner with no plateau at 1-2 servings per week. The biggest reduction 263 
in risk may well occur between zero servings and 1-2 servings per week, but to suggest that there 264 
is no additional benefit at high intakes and blood levels ignores a substantial body of evidence 265 
cited above. We do recognize that public health recommendations must balance what is ideal vs. 266 
what is practical for the public, and also must take into consideration other non-nutritional 267 
factors, i.e. potentially hazadous components of fish (mercury, PCBs) and the sustainability of 268 
the world’s fish supply. However, the basis for concluding that there is “no evidence” that higher 269 
fish intakes are associated with improved outcomes is obscure at best.   270 
Why is an O3I of 8% the desirable level? The O3I was originally presented as a risk 271 
factor for cardiac death, which is where the cut-offs for desirable (>8%) and undesirable (<4%) 272 
[10] were estimated from the data available prior to 2004. Recently, a meta-analysis from 10 273 
prospective cohort studies has confirmed that an 8% O3I was associated with a 35% reduction in 274 
risk for fatal CHD compared to an Index of <4% [9, 27]. In another report, a level of 8% or 275 
greater (extrapolated from whole blood EPA+DHA levels) was significantly associated with the 276 
slowest rate of telomere attrition [13], and in the Women’s Health Initiative Memory Study, 277 
those with an Index of 8% or greater had a 31% lower risk of death from any cause over the 278 
ensuing 15 years [13]. Similarly, individuals with a O3I of 7.8% (median of the highest quintile 279 
in the Framingham Offspring Study) were 34% less likely to die from any cause over 7 years of 280 
follow-up compared to those with an Index of 3.7% (median of the lowest quintile) [28]. In 281 
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addition, an Index at this level was linked with better cognitive performance [11], improved 282 
depressive symptoms [29, 30], better cardiac remodeling post myocardial-infarction [31], lower 283 
odds of being an acute coronary syndrome patient [32], improved arthritis symptoms [33], and 284 
better cognitive function/brain size in B-vitamin-treated subjects [34]. This is also the range 285 
typical of the traditional Japanese [35], a population with a very low CHD rate and one of the 286 
longest life-expectancies in the world [36]. Finally, as emphasized by Myer and DeGroot, RCTs 287 
which achieved an O3I of 8% were more likely to see CVD benefits [37]. Thus, there is 288 
substantial evidence supporting a target of 8% or more as optimal.   289 
Although an O3I of 8% is a reasonable therapeutic target, is it realistic? Can it be 290 
achieved with diet alone? Clearly, it can, again based on the Japanese experience. There, the 291 
median fish consumption is ~3 fish servings per week, resulting in an estimated 750 – 1,000 mg 292 
EPA+DHA per day[4, 38]. Interestingly, this intake is similar to the ~835 mg/day calculated 293 
above for 3 fish meals + supplementation. The average erythrocyte EPA+DHA levels in Japan 294 
range from 6.8 – 9.0%, depending on the study and population [4, 38, 39]. So, yes, an O3I >8% 295 
is achievable by diet alone.  But Japan is fairly unique. In the US the average fish intake is less 296 
than 1 serving per week which provides approximately 100 mg EPA+DHA per day [24]). The 297 
average O3I for Americans ranges from 4%-6% [25]. So, short of adopting the Japanese diet (for 298 
a lifetime), it appears that taking an EPA+DHA supplement could be an important for achieving 299 
a cardioprotective O3I. The O3I calculator (https://omegaquant.com/omega-3-calculator/) is a 300 
useful tool to roughly estimate how much more EPA+DHA one needs to eat in order to achieve a 301 
desirable O3I level based on their current levels and intake [8]. For example, according to the 302 
calculator, a man with an O3I of 4.5% would need an estimated 951 mg EPA+DHA per day to 303 
reach 8%. To get ~950 mg EPA+DHA per day, he could start by eating three wild sockeye 304 
salmon meals per week (at 974 mg EPA+DHA per 4-oz. serving), which would amount to 417 305 
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mg EPA+DHA per day [21]. Then he could add at least 500 mg EPA+DHA per day through 306 
taking a supplement, for a total of 917 mg EPA+DHA per day. Alternatively, he could achieve 307 
this intake by eating oily fish almost every day: two servings of sockeye salmon (974 mg 308 
EPA+DHA per 4 oz serving), two cans of Albacore tuna (1483 mg EPA+DHA) and two cans of 309 
sardines (903 mg EPA+DHA) per week.  Or finally, he could eat no fish at all and take 3 310 
standard fish oil capsules per day (900 mg EPA+DHA). Whatever the approach, it would need to 311 
be consistent for at least 4 months in order to reach a new steady state O3I[40].  312 
This study had significant limitations which may have contributed to the wide variability 313 
in the O3I across intake/supplementation categories. First, the single fish question was vague 314 
with regards to the actual types of fish consumed, and the supplement question did not take doses 315 
and frequency of supplementation into account. This is the price one pays for creating simple, 316 
consumer-directed questions instead of complex, research-based questions. Second, individual 317 
variability in O3I levels could be due to genetic and biological differences (age [25], genetic 318 
variants [41]) affecting the incorporation of FAs into tissue. Finally, there is always the chance 319 
that the individuals misreported their dietary intake, making the relationship between the 320 
reported intake and O3I seem incongruent on an individual basis. Therefore, these two questions, 321 
although useful at a population level, are probably less so for the individual.  It should be 322 
emphasized that this cohort is in no way “representative” of the omega-3 status of each 323 
individual country from which these samples were collected. These individuals were typically 324 
attending trade shows and thus were much more likely to be interested in omega-3 FAs than the 325 
average person, and hence probably consumed more fish/fish oil.  Thus, these data are not 326 
generalizable to the populations tested, but they were appropriate to address our study question. 327 
This was also a cross sectional study in which only one blood sample and only one response to 328 
the questions asked were available. Multiple data points per person would likely have reduced 329 
17 
 
the variability. There were also significant strengths with this study, including the large, real-330 
world cohort with self-reported dietary intake, the use of an objective FA biomarker of omega-3 331 
status, and the inclusion of a well-validated and widely-used dietary intake tool.  332 
5. CONCLUSION 333 
 The current study again validates the O3I as a useful biomarker of EPA+DHA intake.  334 
Reports of higher fish intake corresponded with higher O3I values in a dose-dependent manner. 335 
Reported supplementation with EPA+DHA (fish, krill, or algal oils) was associated with an 336 
approximately 2 percentage point higher O3I. The current fish intake recommendations (1-2 337 
servings of seafood per week) are unlikely to produce a cardioprotective O3I level, but 338 
consuming primarily oily fish 3 times or more per week and supplementation may. Despite these 339 
strong relationships, individual variability is great, and testing blood levels is the only way to 340 
confirm the omega-3 status.  341 
  342 
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Table 1. Study 1 demographic, (mean [SD], n[%]) 481 
Characteristic 
Overall 
(n=28) 
<1 time per 
month (n=6) 
2-3 times per 
month (n=6) 
1 time per 
week (n=5)1 
2 times per 
week (n=5) 
More than 2 times 
per week (n=6) 
Demographics 
Sex – Male 25% (7) 16.7% (1) 16.7% (1) 20% (1) 0% (0) 66.7% (4) 
Age (years) 31.6 (9.5) 30.3 (12.0) 34.2 (10.3) 30.2 (6.8) 27.0 (7.5) 35.3 (10.2) 
Race  - Caucasian 82.1% (23) 83.3% (5) 83.3% (5) 60% (3) 100% (5) 83.3% (5) 
BMI (kg/m2) 24.3 (4.5) 21.9 (3.4) 25.9 (4.8) 27.0 (4.9) 24.2 (6.0) 22.9 (2.7) 
Whole blood fatty acid levels (% composition) 
EPA 0.57 (0.43) 0.34 (0.06) 0.43 (0.17) 0.55 (0.28) 0.60 (0.27) 0.93 (0.78) 
DHA 3.40 (0.95) 2.57 (0.79) 2.79 (0.52) 3.63 (0.55) 4.10 (0.21) 4.05 (1.16) 
Omega-3 Index1 4.87 (1.34) 3.77 (0.83) 4.08 (0.52) 5.10 (0.87) 5.65 (0.45) 5.94 (1.94) 
Calorie-Adjusted Dietary Intake (g per 1000 kcal) 
EPA 0.05 (0.07) 0.004 (0.002) 0.02 (0.03) 0.06 (0.04) 0.05 (0.04) 0.12 (0.12) 
DHA 0.10 (0.12) 0.014 (0.008) 0.06 (0.11) 0.09 (0.09) 0.15 (0.13) 0.19 (0.16) 
EPA+DHA 0.15 (0.18) 0.017 (0.01) 0.08 (0.14) 0.15 (0.13) 0.21 (0.16) 0.31 (0.26) 
 482 
1The O3I is EPA+DHA in erythrocytes which is calculated from the EPA+DHA content of a 483 
dried whole blood sample. Hence, the O3I may not equal the EPA+DHA in whole blood. 484 
  485 
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Table 2. Association of fish intake and other characteristics with O3I levels in Study 1.  486 
Characteristic Absolute percentage point difference in the O3I 
per unit of change of the characteristic 1 
 Bivariate 
Beta (95% CI) 
Multivariable2 
Beta (95% CI) 
Fish consumption category 
(meals/week) 
0.65% (0.31, 1.00)† 0.56% (0.06, 1.07)* 
EPA+DHA consumption (per 
1000 kcal; log-transformed)2 
0.33% (0.04, 0.63)* 0.17% (-0.24, 0.57) 
Sex- Male 0.49% (-0.72, 1.71) -0.32% (-1.50, 0.87) 
Age (per decade) -0.22% (-0.75, 0.33) -0.20% (-0.72, 0.29) 
Caucasian Race 0.05% (-1.33, 1.45) -0.18% (-1.42, 1.04) 
BMI (kg/m2) -0.07% (-0.18, 0.05) -0.05% (-0.18, 0.07) 
†P<0.0001; *P<0.01 487 
1Values in this table are beta coefficients and are interpreted as the change in O3I for a one-unit 488 
change in the characteristic, e.g. for each additional fish meal per week the estimated effect on 489 
O3I is 0.65 percentage point increase before and 0.56 percentage point increase after adjusting 490 
for other characteristics. 2Model R2 is 0.45. Equation: O3I = 6.62% + 0.56*Estimated fish meals 491 
per week + 0.17*log(EPA+DHA)-0.32*Male-0.20*(Age/10)-0.18*White-0.05*BMI.  492 
  493 
  494 
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Table 3. Demographics, fish intake, supplementation status and blood fatty acids from 495 
study 2 (n=3458) 496 
Characteristic n (%) or Mean (SD) 
Demographics  
Age 51.3 (17.0) 
Sex – Male 40.2% (1391) 
Country – USA 84.2% (2912)1 
Supplementation  
None 47.9% (1657) 
Any 52.1% (1800) 
   Fish (EPA/DHA) oil 43.6% (1508) 
   Flaxseed (ALA) oil 1.3% (45) 
   Krill (EPA/DHA) oil 3.2% (111) 
   Algal (EPA/DHA) oil 1.8% (62) 
   Unknown 2.1% (74) 
Reported fish intake  
   None 31.5% (1090) 
   Every other week  30.9% (1067) 
   Weekly 20.6% (714) 
   Twice per week 10.2% (353) 
   Three or more times per week 6.8% (234) 
O3I value  
   Less than 8% 82.6% (2855) 
   8-12% 15.6% (540) 
   Above 12% 1.8% (63) 
1. Non-US individuals (n=546), were from 27 other countries 497 
(Singapore (110), India (87), Chile (58), New Zealand (36), 498 
Canada (33), Australia (33), Korea (24), Japan (21), United 499 
Kingdom (19), Norway (19), Philipines (17), Hong Kong (14), 500 
South Africa (13), China (8), Taiwan (5), Sweden (4), 501 
Denmark (4), United Arab Emirates (3), Switzerland (2), 502 
Pakistan (2), Iceland (2), Uruguay (1), Saudia Arabia (1), 503 
Netherlands (1), Mexico (1), Brazil (1) and Brunei (1). 504 
Twenty-six individuals had an unknown country of origin. 505 
  506 
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Table 4. Association between demographic, dietary and supplementation status and O3I 507 
values in study 2 508 
Characteristic Absolute percentage point increase in O3I per unit of 
change1 
 Bivariate 
Beta (95% CI) 
Multivariable2 
Beta (95% CI) 
Reported fish meals/week   
   Never -- -- 
   Bi-weekly 0.49% (0.31%, 0.68%)† 0.29%† (0.12%, 0.45%) 
   Weekly 1.08% (0.87%, 1.28%)† 0.65%† (0.46%, 0.83%) 
   Twice weekly 1.68% (1.42%, 1.94%)† 1.18%† (0.95%, 1.41%) 
   Three or more per week 2.57% (2.27%, 2.88%)† 1.90%* (1.63%, 2.18%) 
EPA/DHA Supplement - Yes 2.36% (2.23%, 2.50%)† 2.16%† (2.03%, 2.29%) 
Sex - Male -0.09% (-0.25%, 0.06%) -0.10% (-0.23%, 0.04%) 
Age (years/10) 0.22%† (0.18%, 0.27%) 0.09%† (0.05%, 0.13%) 
Country – Not USA3 0.30%* (0.09%, 0.51%) 0.45%† (0.27%, 0.63%) 
†P<0.0001, *P<0.01 509 
1Values in this table are beta coefficients and are interpreted as the percentage point change in 510 
O3I for a one-unit change in the characteristic, e.g. for each additional fish meal per week the 511 
estimated effect on O3I is 0.6% (or a 0.6 percentage point increase) both before and after 512 
adjusting for other characteristics. 513 
2Overall model R2 is 0.33.  514 
Equation: O3I = 4.02%+0.29*Biweekly+0.65*Weekly+1.18*Twice+ 515 
1.90*Three+2.16*Supplement-0.10*Male+0.09*(Age/10)+0.45*Not USA 516 
 517 
3We also considered a multivariable model which considered groups of non-US countries instead 518 
of a US vs. non-US variable. In this more complex model each region was compared to the US, 519 
with betas (95% CIs) as follows: Asia 0.49% (0.26, 0.73%)†, Europe 0.92% (0.40%, 1.45%)†, 520 
South America -0.01% (-0.51%, 0.51%), Africa -0.17% (-1.13%, 0.78%), Australia/NZ 0.32% (-521 
0.15%, 0.79%), Canada 0.95% (0.29%, 1.61%)* and Unknown 0.05% (-0.68%, 0.76%).  522 
  523 
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Table 5. Seventy-five percent1 prediction intervals based on multivariable model from 524 
study 22  525 
Fish consumption Supplement Not supplement 
   Never 6.61% (4.43, 8.79) 4.48% (2.30, 6.65) 
   Bi-weekly 6.91% (4.74, 9.09) 4.78% (2.60, 6.96) 
   Weekly 7.28% (5.10, 9.46) 5.14% (2.96, 7.32) 
   Twice weekly 7.84% (5.66, 10.02) 5.71% (3.53, 7.89) 
   Three or more per week 8.59% (6.41, 10.77) 6.46% (4.28, 8.64) 
 526 
1Seventy-five percent of people were within the range shown. For example, seventy-five percent 527 
of people eating fish three or more times per week and taking an omega-3 supplement had O3I 528 
values between 6.41 and 10.77%. 529 
2Based on model predicting O3I by supplement, fish consumption and age only. Predictions are 530 
made for someone 50 years old.  531 
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 533 
Figure 1. Omega-3 Index by fish intake and supplementation groups from Study 2 (mean ± SD). 534 
 535 
